Roughly 40 million American adults experience an anxiety disorder in any given year, and nearly one in three will deal with one at some point in their lives. That makes anxiety disorders the most common mental health condition in the United States by a wide margin. But the full picture goes beyond a single number, because anxiety affects different groups at different rates, shows up in several distinct forms, and goes untreated far more often than most people realize.
Anxiety by the Numbers
The lifetime figure is striking: approximately 31% of U.S. adults will meet the clinical criteria for an anxiety disorder during their lives. In a single year, the number of affected adults sits around 40 million, though estimates vary slightly depending on which surveys and diagnostic criteria researchers use. These aren’t people who feel stressed before a job interview. Clinical anxiety involves persistent, outsized worry or fear that interferes with daily functioning for weeks or months at a time.
Children and teenagers are affected too. CDC data from 2022 to 2023 shows that 11% of kids ages 3 to 17 have a current, diagnosed anxiety disorder. That’s roughly 1 in 9 children, making anxiety one of the most common childhood mental health conditions alongside ADHD.
Types of Anxiety Disorders
Anxiety isn’t a single condition. It’s an umbrella term covering several disorders, each with its own patterns and prevalence.
Generalized anxiety disorder (GAD) affects about 6.8 million American adults, or 3.1% of the population in a given year. People with GAD experience persistent, hard-to-control worry about multiple areas of life, often without a clear trigger. Over a lifetime, roughly 5.7% of adults will develop it.
Social anxiety disorder involves intense fear of social situations and is one of the most common anxiety subtypes, typically emerging in the teenage years. Panic disorder, characterized by sudden episodes of overwhelming physical fear (racing heart, shortness of breath, a feeling of losing control), affects a smaller but significant share of the population. Specific phobias, separation anxiety, and agoraphobia round out the category. Many people live with more than one type simultaneously, and anxiety disorders frequently overlap with depression.
Who Is Most Affected
Women experience anxiety at consistently higher rates than men across every measure researchers track. CDC data from 2019 found that 19% of women reported anxiety symptoms in the prior two weeks, compared with 11.9% of men. That gap holds at every severity level: women were nearly twice as likely as men to report moderate symptoms (4.3% vs. 2.4%) and severe symptoms (3.5% vs. 1.9%). NIMH data on generalized anxiety disorder specifically shows past-year rates of 3.4% for women and 1.9% for men.
The gender gap appears early. Among adolescents with generalized anxiety disorder, 3% of girls are affected compared with 1.5% of boys. Similarly, the CDC’s data on children ages 3 to 17 shows diagnosed anxiety in 12% of girls and 9% of boys.
Several factors likely contribute to this difference, including hormonal influences, higher rates of trauma exposure, and differences in how men and women report symptoms. Some researchers also note that men may be underdiagnosed because they’re less likely to seek help or describe their experiences using the language clinicians screen for.
The Treatment Gap
Despite being highly treatable, anxiety disorders go unaddressed in the majority of cases. Among adults with generalized anxiety disorder, only 43.2% are receiving treatment. That means more than half of the nearly 7 million people affected are managing without professional support, whether by choice, due to cost, or because they don’t recognize their symptoms as a treatable condition.
The gap matters because untreated anxiety tends to persist and often worsens. It can erode work performance, strain relationships, and increase the risk of developing depression or substance use problems. People with untreated anxiety are also more likely to visit emergency rooms and primary care doctors for physical symptoms (chest pain, headaches, digestive problems) that are actually driven by chronic stress and worry.
The Financial Cost
Anxiety’s impact extends to the economy. Medical spending on anxiety and mood disorders totaled $36.8 billion in 2007, the most recent comprehensive federal estimate available. Half of that, roughly $18.4 billion, went to prescription medications. For individuals receiving treatment, the average annual cost was $1,374 per person. Adjusted for inflation and rising healthcare costs, today’s figure is almost certainly much higher.
Those numbers capture only direct medical spending. They don’t account for lost productivity, reduced work hours, disability claims, or the downstream effects on families and caregivers. When those indirect costs are factored in, anxiety disorders represent one of the most expensive mental health conditions in the country, comparable to depression in total economic burden.
Why the Numbers Keep Rising
Anxiety prevalence has climbed over the past two decades, with a particularly sharp increase during and after the COVID-19 pandemic. Several forces are at play. Greater public awareness and reduced stigma mean more people are willing to report symptoms and seek diagnosis. Screening tools are now routine in primary care settings, catching cases that would have gone undetected a generation ago.
But awareness alone doesn’t explain the trend. Financial instability, social media use, climate-related stress, and the lingering effects of pandemic isolation have all been linked to rising anxiety levels, especially among young adults and adolescents. The 11% childhood diagnosis rate represents a meaningful increase from pre-pandemic levels, and mental health providers across the country report sustained demand that outpaces available appointments.
The takeaway is that anxiety is not a niche condition. It affects tens of millions of Americans across every age group, gender, and background, and more than half of those affected are navigating it without professional help.